Improving Confidence in Observational Studies Eberechukwu Onukwugha Editorial 22 January 2013 Pages: 177 - 179
What Evidence Is There for the Reimbursement of Personalised Medicine? Peter S. HallChristopher McCabe Commentary 23 February 2013 Pages: 181 - 183
Trastuzumab for the Treatment of HER2-Positive Metastatic Gastric Cancer Eldon SpackmanStephen RiceStephen Palmer Review Article 01 February 2013 Pages: 185 - 194
Cost Effectiveness of Antiarrhythmic Medications in Patients Suffering from Atrial Fibrillation Bernd BrüggenjürgenStefan KohlerStefan N. Willich Review Article 27 February 2013 Pages: 195 - 213
Influence of Pharmacogenomic Profiling Prior to Pharmaceutical Treatment in Metastatic Colorectal Cancer on Cost Effectiveness Martin FrankThomas Mittendorf Systematic Review 22 January 2013 Pages: 215 - 228
The Evaluation and Use of Economic Evidence to Inform Cancer Drug Reimbursement Decisions in Canada Jean H. E. YongJaclyn BecaJeffrey S. Hoch Original Research Article 16 January 2013 Pages: 229 - 236
The Economic Burden of Depression in Switzerland Yuki TomonagaJosef HaettenschwilerThomas D. Szucs Original Research Article 16 February 2013 Pages: 237 - 250
The State of Health Economic Research in South Africa Jeff GowMichael StraussAlan Whiteside Correspondence 13 February 2013 Pages: 251 - 253
The Authors’ Reply to Gow et al.: “The State of Health Economic Research in South Africa” Paul GavazaKaren L. RascatiStar Khoza Correspondence 21 February 2013 Pages: 255 - 256